About Wobble Genomics
Wobble Genomics is a company based in Edinburgh (United Kingdom) founded in 2020 by Richard Kuo.. Wobble Genomics has raised $12.46 million across 2 funding rounds from investors including Mercia, BGFG and Eos Capital Advisors. The company has 6 employees as of June 30, 2022. Wobble Genomics operates in a competitive market with competitors including Metabolon, Maze Therapeutics, Alector, Seer and Tango Therapeutics, among others.
- Headquarter Edinburgh, United Kingdom
- Employees 6 as on 30 Jun, 2022
- Founders Richard Kuo
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Wobble Genomics Limited
- Date of Incorporation 06 Apr, 2021
- Jurisdiction EDINBURGH, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.46 M (USD)
in 2 rounds
-
Latest Funding Round
$10.81 M (USD), Series A
Dec 22, 2023
-
Investors
Mercia
& 6 more
-
Employee Count
6
as on Jun 30, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Wobble Genomics
Wobble Genomics has successfully raised a total of $12.46M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $10.81 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $10.8M
-
First Round
First Round
(02 Sep 2021)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Series A - Wobble Genomics | Valuation | Mercia , BGFG | |
| Sep, 2021 | Amount | Seed - Wobble Genomics | Valuation | Eos Advisory |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Wobble Genomics
Wobble Genomics has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Mercia, BGFG and Eos Capital Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deep tech venture capital firm investing in European and global startups.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Investment in science and technology is managed by Eos.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Wobble Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Wobble Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Wobble Genomics Comparisons
Competitors of Wobble Genomics
Wobble Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Metabolon, Maze Therapeutics, Alector, Seer and Tango Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| domain | founded_year | HQ Location |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| domain | founded_year | HQ Location |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| domain | founded_year | HQ Location |
Novel cancer drugs are developed using synthetic lethality screening.
|
|
| domain | founded_year | HQ Location |
NeoPhore is focused on cancer neoantigen evolution therapies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Wobble Genomics
Frequently Asked Questions about Wobble Genomics
When was Wobble Genomics founded?
Wobble Genomics was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Wobble Genomics located?
Wobble Genomics is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.
Is Wobble Genomics a funded company?
Wobble Genomics is a funded company, having raised a total of $12.46M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.65M, raised on Sep 02, 2021.
How many employees does Wobble Genomics have?
As of Jun 30, 2022, the latest employee count at Wobble Genomics is 6.
What does Wobble Genomics do?
Wobble Genomics was founded in 2020 in Edinburgh, United Kingdom, within the genomics sector. A platform for nucleic acid biomarker discovery is offered, incorporating cDNA normalization technology called Level-Up to support non-targeted sequencing for biomarker identification. TAMA RNA sequencing bioinformatics software is also provided to facilitate gene detection. Operations focus on these tools for research applications in the United Kingdom.
Who are the top competitors of Wobble Genomics?
Wobble Genomics's top competitors include Alector, Lexicon Pharmaceuticals and Maze Therapeutics.
Who are Wobble Genomics's investors?
Wobble Genomics has 7 investors. Key investors include Mercia, BGFG, Eos Capital Advisors, IQ Capital, and Old College Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.